InTrack Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
WAM
CRM
VNIM
InTrack Investment Management's LLY Position: Q2 2026 in Review
InTrack Investment Management reduced its Eli Lilly (LLY) stake by 3% in Q2 2026, selling an estimated $111K and leaving 3,505 shares worth $4.2M. The position accounts for 2.08% of the portfolio, ranked #13.
InTrack Investment Management first reported a position in LLY in Q1 2023 and has held it in 14 quarters since. 961 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- InTrack Investment Management held 3,505 shares of Eli Lilly worth $4.2M as of Q2 2026.
- InTrack Investment Management sold 109 Eli Lilly shares in Q2 2026, an estimated $111K.
- Eli Lilly made up 2.08% of InTrack Investment Management's portfolio in Q2 2026, its #13 holding.
- InTrack Investment Management first reported a position in Eli Lilly in Q1 2023 and has held it in 14 quarters since.
- 961 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on InTrack Investment Management's 13F filing for Q2 2026, filed 17 Jul 2026.